Search Results - "Shimozuma K"

Japanese value set for the EORTC QLU-C10D: A multi-attribute utility instrument based on the EORTC QLQ-C30 cancer-specific quality-of-life questionnaire.

Authors: Shiroiwa, T. King, M. T. Norman, R. et al.

Source: Quality of Life Research. Jul2024, Vol. 33 Issue 7, p1865-1879. 15p.

Subjects: Quality of life, Life expectancy, Fatigue (Physiology), Physical mobility, Social skills

Geographic Terms: Japan

Psychometric properties of the Japanese version of the EQ-5D-Y by self-report and proxy-report: reliability and construct validity.

Authors: Shiroiwa, T. Fukuda, T. Shimozuma, K.

Source: Quality of Life Research. Nov2019, Vol. 28 Issue 11, p3093-3105. 13p. 11 Charts, 1 Graph.

Subjects: Test validity, Test reliability, Self-evaluation, Rank correlation (Statistics), Mental health, Quality of life, Guardian & ward, Parents, Psychometrics, Questionnaires, Research evaluation, Research funding, Translations

Geographic Terms: Japan

Long-term health status as measured by EQ-5D among patients with metastatic breast cancer: comparison of first-line oral S-1 and taxane therapies in the randomized phase III SELECT BC trial.

Authors: Shiroiwa, T. Fukuda, T. Shimozuma, K. et al.

Source: Quality of Life Research. Feb2017, Vol. 26 Issue 2, p445-453. 9p.

Subjects: Breast cancer patients, Health status indicators, Quality of life, Metastasis, Taxanes, Randomized controlled trials, Fluorouracil, Hydrocarbons, Heterocyclic compounds, Breast tumors, Combination drug therapy, Comparative studies, Research methodology, Medical cooperation, Questionnaires, Research, Evaluation research, Quality-adjusted life years, Therapeutics, Cancer & psychology

Japanese value set for the Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D) cancer-specific preference-based quality of life instrument.

Authors: Shiroiwa, T. King, M. T. Campbell, R. et al.

Source: Health & Quality of Life Outcomes. 10/29/2025, Vol. 23 Issue 1, p1-15. 15p.

PCR154 Health State Utility Values in COVID-19: A Vignette Study in Japan.

Authors: Noto, S Shimozuma, K Iwatani, T et al.

Source: Value in Health. 2024 Supplement, Vol. 27 Issue 6, pS325-S325. 1p.

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02.

Authors: Shimozuma K Ohashi Y Takeuchi A et al.

Source: Supportive Care in Cancer. Dec2009, Vol. 17 Issue 12, p1483-1491. 9p.

PCR102 Relationship between Health-State Utility Values, Self-Efficacy, and Health Locus of Control in the General Population.

Authors: Noto, S. Shimozuma, K. Fukuda, T. et al.

Source: Value in Health. 2023 Supplement, Vol. 26 Issue 6, pS330-S330. 1p.

Development of quality of life questionnaire in Japan: quality of life assessment of cancer patients receiving chemotherapy.

Authors: Kurihara M Shimizu H Tsuboi K et al.

Source: Psycho-Oncology. Jul/Aug1999, Vol. 8 Issue 4, p355-363. 9p.

Cost-effectiveness analysis of trastuzumab to treat HER2-positive advanced gastric cancer based on the randomised ToGA trial.

Authors: Shiroiwa, T Fukuda, T Shimozuma, K

Source: British Journal of Cancer. 10/25/2011, Vol. 105 Issue 9, p1273-1278. 6p. 1 Diagram, 4 Charts, 2 Graphs.

PMH12 - A Cost-Effectiveness Analysis of Guanfacine Extended-Release Treatment in Pediatric Attention-Deficit/Hyperactivity Disorder.

Authors: Maeda, S Shimozuma, K Takeda, Y

Source: Value in Health. Nov/Dec2016, Vol. 19 Issue 7, pA841-A841. 1p.

PCN204 - Impacts of Adverse Events on Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results From Randomized Phase III Select BC Study.

Authors: Hagiwara, Y Shimozuma, K Shiroiwa, T et al.

Source: Value in Health. Nov/Dec2016, Vol. 19 Issue 7, pA745-A745. 1p.

Effects Of Adverse Events On Quality Of Life Scores In A Randomized Clinical Trial Of Adjuvant Chemotherapy For Breast Cancer: N-Sas Bc 02.

Authors: Kunisawa, S Shimozuma, K Tange, C et al.

Source: Value in Health. Nov2015, Vol. 18 Issue 7, pA473-A473. 1p.

A Comparison of Value for Health States Worse Than Dead Between Japan and Uk.

Authors: Noto, S. Shimozuma, K. Saito, S. et al.

Source: Value in Health. Nov2014, Vol. 17 Issue 7, pA514-A514. 1p.

Treatment Costs for Breast Cancer in Japan: Large Claim Database Analysis.

Authors: Shiroiwa, T Shimozuma, K Fukuda, T

Source: Value in Health. Nov2014, Vol. 17 Issue 7, pA735-A735. 1p.

Assessment of Response Shift and True Change Using Structural Equation Modeling for Health–Related Quality-of-Life Scores in Patients with Breast Cancer After Surgery.

Authors: Nakamura, K. Shimozuma, K. Suzukamo, Y. et al.

Source: Value in Health. May2014, Vol. 17 Issue 3, pA94-A94. 1p.

Using Structural Equation Modeling to Detect Response Shift and True Change in Health-Related Quality-Of-Life Scores of Breast Cancer Patients After Surgery.

Authors: Nakamura, K. Shimozuma, K. Suzukamo, Y. et al.

Source: Value in Health. Nov2013, Vol. 16 Issue 7, pA602-A602. 1p.

Impact of preservation of the intercostobrachial nerve during axillary dissection on sensory change and health-related quality of life two years after breast cancer surgery.

Authors: Taira, N. Shimozuma, K. Ohsumi, S. et al.

Source: Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p1329-1329. 1p.

PCN132 A Development of Quality Indicators for Evaluating Home Palliative Care and Their Relation with Bereaved Family Satisfaction

Authors: Saito, S. Shimozuma, K. Yamaguchi, M. et al.

Source: Value in Health. pA458-A458. 1p.

PSU23 Rehabilitation Needs and Predictive Factors of Health-Related Quality-of-Life in Breast Cancer Patients During Two Years After Surgery - A Multicenter Prospective Study

Authors: Shimozuma, K. Taira, N. Shiroiwa, T. et al.

Source: Value in Health. pA264-A264. 1p.

HTA42 Vignette-Based Estimation of Utilities in Patients with Metastatic Breast Cancer in Japan.

Authors: Yamaguchi, M Moriwaki, K Shimozuma, K

Source: Value in Health. 2024 Supplement, Vol. 27 Issue 6, pS252-S252. 1p.